These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7460420)

  • 1. [Urinary excretion of methylamino acids in myogenic and neurogenic muscular atrophy (author's transl)].
    Inoue R
    Rinsho Shinkeigaku; 1980 Jul; 20(7):510-5. PubMed ID: 7460420
    [No Abstract]   [Full Text] [Related]  

  • 2. Decrease of 3-methylhistidine and increase of NG,NG-dimethylarginine in the urine of patients with muscular dystrophy.
    Inoue R; Miyake M; Kanazawa A; Sato M; Kakimoto Y
    Metabolism; 1979 Aug; 28(8):801-4. PubMed ID: 454517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases.
    Warnes DM; Tomas FM; Ballard FJ
    Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urinary 3-methylhistidine excretion in children with neuromuscular diseases].
    Kumagai T; Takeuchi T; Hara K; Miyazaki S; Riko T; Shionoya T; Komatsu K; Mizutani N; Watanabe K
    No To Hattatsu; 1984 Nov; 16(6):445-9. PubMed ID: 6518118
    [No Abstract]   [Full Text] [Related]  

  • 5. 3-Methylhistidine excretion as an index of myofibrillar protein catabolism in neuromuscular disease.
    McKeran RO; Halliday D; Purkiss P; Royston P
    J Neurol Neurosurg Psychiatry; 1979 Jun; 42(6):536-41. PubMed ID: 469561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary amino acids in progressive muscular dystrophy and amyotonia congenita].
    BAUZA C
    Arch Pediatr Urug; 1959 Dec; 30():749-55. PubMed ID: 13797772
    [No Abstract]   [Full Text] [Related]  

  • 7. Excretion of total and muscular N tau-methylhistidine and creatinine in muscle diseases.
    Röthig HJ; Bernhardt W; Afting EG
    Muscle Nerve; 1984 Jun; 7(5):374-9. PubMed ID: 6738575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary 3-methylhistidine and urinary 3-methylhistidine/creatinine ratio in Duchenne-muscular dystrophy in hemizygotes and in gene-carriers.
    László A; Klujber L
    Acta Paediatr Hung; 1984; 25(4):339-41. PubMed ID: 6525307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of 3-methylhistidine and creatine in carriers of Duchenne muscular dystrophy.
    Maskrey P; Harris CI; Milne G; Lane RJ; Pennington RJ
    Clin Chim Acta; 1979 May; 94(1):89-91. PubMed ID: 455721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis of creatinuria and aminoaciduria in neuromuscular diseases].
    Il'ina NA; Poliakova NF; Khokhlov AP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(7):1025-8. PubMed ID: 197760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
    Mussini E; Cornelio F; Colombo L; De Ponte G; Giudici G; Cotellessa L; Marcucci F
    Muscle Nerve; 1984 Jun; 7(5):388-91. PubMed ID: 6738577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
    McKeran RO; Halliday D; Purkiss P
    J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):979-81. PubMed ID: 591977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-methylhistidine excretion in myotonic dystrophy.
    Griggs RC; Moxley RT; Forbes GB
    Neurology; 1980 Dec; 30(12):1262-7. PubMed ID: 7192806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical usefulness of urinary 3-methylhistidine excretion in indicating muscle protein breakdown.
    Elia M; Carter A; Bacon S; Winearls CG; Smith R
    Br Med J (Clin Res Ed); 1981 Jan; 282(6261):351-4. PubMed ID: 6780020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aminoaciduria in patients with progressive muscular dystrophy].
    Yoshino Y; Mozai T
    Rinsho Shinkeigaku; 1972 Apr; 12(4):197-204. PubMed ID: 4674560
    [No Abstract]   [Full Text] [Related]  

  • 16. Aminoaciduria in representative neuromuscular disorders.
    CARVER MJ; DUTCH SJ; WITTSON CL
    Metabolism; 1961 Jul; 10():582-4. PubMed ID: 13691206
    [No Abstract]   [Full Text] [Related]  

  • 17. Paper chromatographic survey of urinary amino-acids in muscular dystrophy.
    Hurwitz LJ; McCormick D
    Br Med J; 1970 Jul; 3(5713):29-30. PubMed ID: 5427484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of methylhistidine analysis in clinical tests].
    Hirayama C; Murawaki Y; Hori T
    Nihon Rinsho; 1989 Dec; 48 Suppl():436-8. PubMed ID: 2621918
    [No Abstract]   [Full Text] [Related]  

  • 19. [Preliminary results in studies of aminoaciduria in progressive muscular dystrophy].
    Górecka A
    Neurol Neurochir Pol; 1969; 3(4):431-8. PubMed ID: 5808903
    [No Abstract]   [Full Text] [Related]  

  • 20. [A clinico-experimental study of amino acid metabolism in progressive muscular dystrophy].
    Badalian LO; Bondarenko ES; Gusev EI; Lukoianov IuE; Revich GG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(9):1304-9. PubMed ID: 5511108
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.